Neomycin proposed regulatory decision

The Australian Pesticides and Veterinary Medicines Authority (APVMA) invites written submissions on the proposed regulatory decision for the reconsideration of neomycin, which was published in the APVMA Special Gazette on 27 February 2024. All submissions will be considered by the APVMA prior to finalisation of the reconsideration and publication of the final regulatory decision.

Making your submission

When making your submission, please include reasons for your comments, supporting them, if possible, with relevant scientific information and indicating the source of the information you have used. Please also include the following information:

• Contact name
• Company or group name (if relevant)
• Postal address
• Email address
• The date you made the submission

Electronic submissions to the APVMA are preferred.

Please lodge your submission with a public submission coversheet, which provides options for how your submission will be published.

Please note: Submissions will be published on the APVMA website unless you have asked for the submission to remain confidential (see public submission coversheet).

Note that all APVMA documents are subject to the access provisions of the Freedom of Information Act 1982 and may be required to be released under that Act should a request for access be made.

Note that all submissions received are subject to legislative requirements, including the Freedom of Information Act 1982, the Privacy Act 1988 and the Agvet Code.

The closing date for submissions is 26 May 2024.

Submissions or requests for further information can be sent to:

Chemical Review
Australian Pesticides and Veterinary Medicines Authority
GPO BOX 3262
Sydney NSW 2001

Telephone: +61 2 6770 2400
Email: chemicalreview@apvma.gov.au

Publication and response to submissions

The APVMA sought comment from interested stakeholders in relation to the proposed decisions on the reconsideration of neomycin.

Submissions received during the consultation period will be reviewed. The submissions, excluding those requested to remain confidential, will be published on the APVMA website either prior to or in conjunction with the Neomycin Final Regulatory Decision. A summary of the submissions and the APVMA's response will be included in the Neomycin Final Review Technical Report when it is published.